ARF1 and prostate carcinoma: We found that mutation of Thr48 to Ser impaired the Golgi localization of ARF1 in prostate cancer DU145 and PC3 cells and the mutant ARF1T48S was largely expressed in the cytoplasm (Figure 5A).